Simplex Trading
GBT

Simplex Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Simplex Trading’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-31,100
Closed -$8K – 11121
2022
Q3 		$8K Buy
31,100
+2,900
+10% +$160K ﹤0.01% 8483
2022
Q2 		$900K Buy
28,200
+500
+2% +$14.6K ﹤0.01% 2738
2022
Q1 		$959K Buy
27,700
+16,800
+154% +$502K ﹤0.01% 2973
2021
Q4 		$319K Buy
10,900
+3,800
+54% +$118K ﹤0.01% 4469
2021
Q3 		$265K Hold
7,100
– – ﹤0.01% 5110
2021
Q2 		$248K Buy
7,100
+6,675
+1,571% +$261K ﹤0.01% 5325
2021
Q1 		$1.73M Sell
425
-766
-64% -$35.2K ﹤0.01% 1772
2020
Q4 		$5.16M Buy
1,191
+1,178
+9,062% +$58.1K 0.01% 972
2020
Q3 		$71K Buy
13
+10
+333% +$636 ﹤0.01% 5269
2020
Q2 		$18K Sell
3
-185
-98% -$12.7K ﹤0.01% 6312
2020
Q1 		$960K Buy
188
+92
+96% +$6.16K ﹤0.01% 1922
2019
Q4 		$763K Sell
96
-33
-26% -$1.96K ﹤0.01% 2335
2019
Q3 		$625K Sell
129
-576
-82% -$30K ﹤0.01% 2380
2019
Q2 		$3.71M Buy
705
+460
+188% +$26.4K 0.01% 868
2019
Q1 		$1.3M Buy
245
+132
+117% +$6.49K ﹤0.01% 1768
2018
Q4 		$463K Sell
113
-242
-68% -$9.07K ﹤0.01% 2307
2018
Q3 		$1.35M Buy
355
+7
+2% +$310 ﹤0.01% 1583
2018
Q2 		$1.57M Buy
348
+270
+346% +$12.3K 0.01% 1349
2018
Q1 		$67K Hold
78
– – ﹤0.01% 2139
2017
Q4 		$31K Sell
78
-21
-21% -$784 ﹤0.01% 2904
2017
Q3 		$9K Buy
99
+26
+36% +$731 ﹤0.01% 3914
2017
Q2 		$37K Buy
73
+3
+4% +$89 ﹤0.01% 2678
2017
Q1 		$8K Sell
70
-18
-20% -$453 ﹤0.01% 4221
2016
Q4 		$49K Sell
88
-33
-27% -$580 ﹤0.01% 2187
2016
Q3 		$40K Buy
121
+81
+203% +$1.54K ﹤0.01% 2307
2016
Q2 		$8K Buy
40
+28
+233% +$565 ﹤0.01% 3858
2016
Q1 		$5K Buy
+12
New +$213 ﹤0.01% 4151

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's GBT Position: Q4 2022 in Review

Simplex Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,250 shares — an estimated $221K sold.

Simplex Trading first reported a position in GBT in Q1 2016 and held it in 16 quarters. The position peaked at $2.52M in Q4 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Simplex Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 3,250 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $221K.
  • Simplex Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 16 quarters.
  • Simplex Trading's Global Blood Therapeutics, Inc. position peaked at $2.52M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.